Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OCUL

+ Watchlist+ Portfolio

Ocular Therapeutix, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$5.94
52-Week Range
$5.77 – $16.44
Market Cap
$1.29B
P/E (TTM)
—
EPS (TTM)
-1.44
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.92
PEG Ratio
—
Return on Equity
-93.48%
Return on Assets
-42.19%
Gross Margin
0.00%
Operating Margin
-680.91%
Profit Margin
0.00%
Current Ratio
9.12
Debt/Equity
0.18
Total Debt
$80.01M
Free Cash Flow
$-159.98M
Revenue Growth
-11.50%
Earnings Growth
—
Enterprise Value
$856.34M

Market Snapshot

About

Biopharmaceutical company developing innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform. The company focuses on sustained-release drug delivery systems that provide extended therapeutic benefits for patients with eye disorders.